STAT+: Top FDA officials weighing regulation of ultra-processed foods, internal documents show
WASHINGTON – Top Food and Drug Administration officials met multiple times earlier this year to…
Category: Medicine
.jpg)
Opinion: Functional neurological disorder is not an appropriate diagnosis for people with long Covid
Long Covid — the name adopted for cases of prolonged symptoms after an acute bout…
Opinion: Letters from readers on schools and bird flu, opioid ‘overprescribing,’ and more
“Preparing schools for the H5N1 bird flu they’re likely to face,” by Mario Ramirez Having…
Expansive new study points to distinct brain networks linked to sex and gender
Our brains are shaped by our experiences — whether you’re a bird watcher, book lover,…
STAT+: Pharmalittle: We’re reading about a study of Ozempic and dementia, smaller PBMs, and more
And so, another working week will soon draw to a close. Not a moment too…
Element Biosciences raises another massive round
Want to stay on top of the science and politics driving biotech today? Sign up to get…
CAR-T therapy’s complications, as well as its benefits, become clearer in ‘flurry’ of cancer studies
Researchers were perplexed when the Food and Drug Administration announced it was investigating whether CAR-T…
STAT+: The biggest misconception about CTE, according to a leading brain trauma expert
This week, the late National Hockey League veteran Greg Johnson was diagnosed with chronic traumatic…
Opinion: Adaptive trial designs will increase clinical trial speed, safety, and effectiveness
Health care is undergoing an important and well-needed shift from a one-size-fits-all approach to more…
Opinion: Unsettling truths about maternal mortality in the U.S.
Grave warnings of a crisis in maternal deaths are being slightly eroded by articles suggesting…
Listen: Biotech layoffs, founder-focused VC, & a big pharma exit
Why are pharmaceutical companies cutting more staff than cash-strapped biotechs? And who will Pfizer scout…
STAT+: Medicare proposes to cover some digital therapies in a breakthrough for health tech firms
In what could prove to be a lifeline for a new crop of health tech…
Alcohol is driving a half-dozen types of cancer in the U.S., study finds
Alcohol has long been classified as a cancer-causing substance, but a study out Thursday gives…
Can you get satiety with GLP-1s without the nausea?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about a Pfizer daily weight loss pill, a Novo Nordisk setback, and more
Rise and shine, another busy day is on the way. However, this is also shaping…
STAT+: Pfizer says it will advance once-daily GLP-1 pill after all
Pfizer said that it plans to advance a new once-a-day formulation of its experimental obesity…
STAT+: Roche’s TIGIT study was a bust. What’s the outlook for its next big bet?
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can…
Opinion: Preparing schools for the H5N1 bird flu they’re likely to face
As Covid-19 swept across the United States, schools were among the most highly affected public…
Elmo and his friends are helping little kids (and grown-ups) with their ‘big feelings’ amid a mental health crisis
WASHINGTON — When Elmo asked “How is everybody doing?” back in January, he was not…
Opinion: Doctors ‘overprescribing’ opioids isn’t the cause of the overdose epidemic — and it never was
A key part of the federal government’s narrative about the epidemic of addiction and overdose…
Medicaid is paying millions for salty, fat-laden ‘medically tailored’ cheeseburgers and sandwiches
WASHINGTON – They’re marketed as healthy, “dietitian-approved” meals and delivered directly to the homes of…
STAT+: Novo Nordisk’s weekly insulin rejected by FDA
The Food and Drug Administration rejected Novo Nordisk’s weekly insulin for the treatment of diabetes…
STAT+: FTC plans to sue PBMs over the high cost of insulin and other medicines, reports say
The U.S. Federal Trade Commission reportedly plans to sue the three largest pharmacy benefit managers…
STAT+: Biden administration ignores calls to bolster hospital price transparency
The federal government will not modify regulations that dictate how hospitals publish their prices for…
STAT+: Sanford Health aims to shake off a run of failed deals by snapping up a $3 billion Wisconsin health system
Fourth time’s the charm? Sanford Health is hoping so. Less than a year after scrapping…
Researchers identify ‘molecular switch’ in lupus that could stymie harmful immune response
Lupus, in superhero terms, tells a devastating story. A loyal hero turns villain and works…
STAT+: Pharmalittle: We’re reading about biopharma layoffs, Purdue bankruptcy talks, and more
Hello, everyone, and how are you today? We are doing just fine, thank you, especially…
uniQure shares soar on Huntington’s data
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: VC Flagship Pioneering raises $3.6 billion in new funds
Flagship Pioneering, one of the largest firms investing in and creating new biotech companies, said…
Opinion: Expand community-based research to make clinical trials more diverse
Innovations in clinical trial designs and tools have the potential to unlock a new era…
Free medical school tuition unlikely to have a major impact on the U.S. health care system
Most of Johns Hopkins University’s medical school students will have free tuition starting this fall,…
.jpg)
Opinion: Listen: Anthony Fauci on presidents, bird flu, and turning down a multimillion-dollar job
Anthony Fauci can’t pinpoint the most meaningful dinner he’s ever had — every time you…
STAT+: Biopharma layoffs are leaving the industry’s scientists reeling — and in search of scarce opportunities
After getting laid off from Bristol Myers Squibb last December, Jennifer Ariazi is trying her…
STAT+: The pharmaceutical industry keeps losing Washington friends
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
A rare voice box transplant helped a cancer patient speak again, part of a pioneering study
WASHINGTON (AP) — A Massachusetts man has regained his voice after surgeons removed his cancerous…
STAT+: Mikael Dolsten, Pfizer CSO who could take on Covid but not Wall Street, to step down
Five years ago — before the pandemic — Pfizer’s head of research and development, Mikael…
Lilly’s obesity drug looks more potent than Novo’s in observational study
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about an FTC report on PBMs, Lilly vs. Novo weight loss study, and more
Top of the morning to you, and a fine one it is. Clear blue skies…
STAT+: FTC report finds PBMs profit at the expense of patients and independent pharmacies
In stark terms, the Federal Trade Commission found in a report released Tuesday that pharmacy…
5 takeaways from the Human Genome Project investigation
The Human Genome Project was among the most ambitious scientific efforts in modern history, with…
Opinion: Everyone deserves addiction treatment that works — including those in jail
The overdose crisis is claiming lives across the United States, but it reaches new depths…
Opinion: STAT+: Private equity and neuroscience: a novel approach to developing new treatments for neurological disorders
Neurological diseases are now the leading cause of poor health and disability worldwide. An estimated…
STAT+: Drugmakers are losing crucial friends on Capitol Hill
WASHINGTON — Sen. Bob Menendez is the poster child for a pharmaceutical industry ally. He…
The untold story of the Human Genome Project: How one man’s DNA became a pillar of genetics
STAT is co-publishing this investigation by Undark. They numbered 20 in all — 10 men…
STAT+: A faster, simpler, cheaper cancer cell therapy is about to be tested in humans
In a long-awaited study, patients in Australia will soon receive an IV infusion designed to…
STAT+: South Africa and J&J reach a deal to widen access to a key tuberculosis treatment
South African antitrust authorities ended an investigation into Johnson & Johnson and its Janssen subsidiary…
Trump’s 2024 platform abandons calls to cut Medicare, broadly restrict abortion
WASHINGTON — Former President Trump says he “will not cut one penny” from Medicare and…
STAT+: Pulling back the curtain on psychiatric hospital joint ventures
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: AI leads the way as health tech funding inches toward a post-pandemic stability
Funding for health tech startups in the first half of 2024 remained far below the…
New study sparks debate about whether H5N1 virus in cows is adapted to better infect humans
A study published Monday provides new evidence that the H5N1 virus currently causing an outbreak…